134 related articles for article (PubMed ID: 34728141)
21. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease previously undergoing a radical nephrectomy or repeated nephron-sparing surgery.
Park SY; Park BK; Kim CK; Lee HM; Jeon SS; Seo SI; Jeong BC; Choi HY
Acta Radiol; 2011 Jul; 52(6):680-5. PubMed ID: 21525107
[TBL] [Abstract][Full Text] [Related]
22. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease.
Ploussard G; Droupy S; Ferlicot S; Ples R; Rocher L; Richard S; Benoit G
Urology; 2007 Sep; 70(3):435-9. PubMed ID: 17905091
[TBL] [Abstract][Full Text] [Related]
23. Long-term followup after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease.
Novick AC; Streem SB
J Urol; 1992 Jun; 147(6):1488-90. PubMed ID: 1593671
[TBL] [Abstract][Full Text] [Related]
24. Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease.
Joly D; Méjean A; Corréas JM; Timsit MO; Verkarre V; Deveaux S; Landais P; Grünfeld JP; Richard S
J Urol; 2011 Jun; 185(6):2056-60. PubMed ID: 21496837
[TBL] [Abstract][Full Text] [Related]
25. Renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease.
Steinbach F; Novick AC; Shoskes D
Urology; 1994 Nov; 44(5):760-3. PubMed ID: 7974953
[TBL] [Abstract][Full Text] [Related]
26. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease.
Shingleton WB; Sewell PE
J Urol; 2002 Mar; 167(3):1268-70. PubMed ID: 11832711
[TBL] [Abstract][Full Text] [Related]
27. Iatrogenic ureteric stricture post image guided renal cryoablation in a patient with von hippel-lindau syndrome.
Ng H; Chan VW; Cartledge J; Kimuli M; Ralph C; Jagdev S; Vasudev N; Bhattarai S; Lenton J; Smith J; Wah TM
Radiol Case Rep; 2021 Aug; 16(8):2057. PubMed ID: 34158894
[TBL] [Abstract][Full Text] [Related]
28. Laparoscopic renal cryoablation using ultrathin 17-gauge cryoprobes: mid-term oncological and functional results.
Beemster PW; Barwari K; Mamoulakis C; Wijkstra H; de la Rosette JJ; Laguna MP
BJU Int; 2011 Aug; 108(4):577-82. PubMed ID: 21044249
[TBL] [Abstract][Full Text] [Related]
29. Management of Renal Malignancies in Von Hippel-Lindau Syndrome: Lessons Learned from a Series of Six Patients from Sri Lanka.
Jayarajah U; Balagobi B; Thanusan V; Gunasekara D; Abeygunasekera AM
Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):187-190. PubMed ID: 38146729
[TBL] [Abstract][Full Text] [Related]
30. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study.
Steinbach F; Novick AC; Zincke H; Miller DP; Williams RD; Lund G; Skinner DG; Esrig D; Richie JP; deKernion JB
J Urol; 1995 Jun; 153(6):1812-6. PubMed ID: 7752324
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
32. First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response.
Roma A; Maruzzo M; Basso U; Brunello A; Zamarchi R; Bezzon E; Pomerri F; Zovato S; Opocher G; Zagonel V
Fam Cancer; 2015 Jun; 14(2):309-16. PubMed ID: 25391617
[TBL] [Abstract][Full Text] [Related]
33. Safety and oncological outcome following radiofrequency ablation of small renal masses in a single center.
Bersang AB; Søndergaard Mosholt KS; Verner Jensen C; Germer U; Holm M; Røder MA
Scand J Urol; 2021 Jun; 55(3):203-208. PubMed ID: 33739218
[TBL] [Abstract][Full Text] [Related]
34. [Clinical study on patients with renal-cell carcinoma accompanied with Von Hippel-Lindau disease treated with radiofrequency ablation].
Nao T; Shimamoto T; Karashima T; Kamei M; Fukuhara H; Fukata S; Satake H; Ashida S; Yamasaki I; Kamata M; Inoue K; Yamanishi T; Ogawa Y; Ito S; Shuin T
Hinyokika Kiyo; 2014 Sep; 60(9):415-20. PubMed ID: 25293793
[TBL] [Abstract][Full Text] [Related]
35. [Radiofrequency ablation for recurred renal cell carcinoma in the solitary kidney due to von Hippel-Lindau disease--indication and tip on how to prevent the thermal injury of the adjacent organs].
Anai H; Nagata T; Sato T; Minoshima K; Horie M; Yoshiya K; Uchida H; Kichikawa K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2303-5. PubMed ID: 21224555
[TBL] [Abstract][Full Text] [Related]
36. Conservative surgical therapy of localized renal cell carcinoma in von Hippel-Lindau disease.
Lund GO; Fallon B; Curtis MA; Williams RD
Cancer; 1994 Nov; 74(9):2541-5. PubMed ID: 7923011
[TBL] [Abstract][Full Text] [Related]
37. Renal Cell Carcinoma and a Pancreatic Neuroendocrine Tumor: A Coincidence or Instance of Von Hippel-Lindau Disease?
Matsubayashi H; Niwakawa M; Uesaka K; Sasaki K; Kiyozumi Y; Ishiwatari H; Hotta K; Imai K; Ito S; Takizawa K; Tanaka M; Kawata N; Kakushima N; Ono H
Intern Med; 2017 Sep; 56(17):2281-2284. PubMed ID: 28794363
[TBL] [Abstract][Full Text] [Related]
38. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
39. Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months.
Zhang J; Pan JH; Dong BJ; Xue W; Liu DM; Huang YR
Fam Cancer; 2012 Jun; 11(2):209-14. PubMed ID: 22203439
[TBL] [Abstract][Full Text] [Related]
40. Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group.
Oudard S; Elaidi R; Brizard M; Le Rest C; Caillet V; Deveaux S; Benoit G; Corréas JM; Benoudiba F; David P; Gaudric A; Hammel P; Joly D; Timsit MO; Méjean A; Richard S
Oncotarget; 2016 Dec; 7(51):85306-85317. PubMed ID: 27852035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
